IMMUNIC, INC. — Form 8-K
Filed July 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Immunic, Inc. (market cap ~$83.1M) filed an 8-K on 2026-07-14 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) containing 35 slide graphics and presentation materials. No specific transaction, deal, financing, partnership, clinical trial result, or business event is disclosed in the filing header or document index. The substance of the disclosure cannot be determined from this filing metadata alone.
Why this rating
Routine disclosure filing with attached presentation slides; no quantified business event, transaction, or material change identified in available filing metadata.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.